Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc.
Taproot Health
Quadriga Biosciences, Inc.
Tocagen Inc.
INSYS Therapeutics Inc
Novartis
Siemens Molecular Imaging